Maria Dobrinas

524 total citations
16 papers, 401 citations indexed

About

Maria Dobrinas is a scholar working on Pharmacology, Molecular Biology and Geriatrics and Gerontology. According to data from OpenAlex, Maria Dobrinas has authored 16 papers receiving a total of 401 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 5 papers in Molecular Biology and 4 papers in Geriatrics and Gerontology. Recurrent topics in Maria Dobrinas's work include Pharmacogenetics and Drug Metabolism (4 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Glutathione Transferases and Polymorphisms (3 papers). Maria Dobrinas is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Glutathione Transferases and Polymorphisms (3 papers). Maria Dobrinas collaborates with scholars based in Switzerland, United States and Spain. Maria Dobrinas's co-authors include Chin B. Eap, Jacques Cornuz, Beatrice Oneda, Nicolas Ansermot, Muriel Noetzli, Eva Choong, Pierre‐Alain Carrupt, Rubin Lubomirov, Chantal Csajka and Margalida Rotger and has published in prestigious journals such as Human Molecular Genetics, Clinical Pharmacology & Therapeutics and Journal of Pharmaceutical and Biomedical Analysis.

In The Last Decade

Maria Dobrinas

16 papers receiving 391 citations

Peers

Countries citing papers authored by Maria Dobrinas

Since Specialization

Citations

This map shows the geographic impact of Maria Dobrinas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Dobrinas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Dobrinas more than expected).

Fields of papers citing papers by Maria Dobrinas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Dobrinas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Dobrinas. The network helps show where Maria Dobrinas may publish in the future.

Co-authorship network of co-authors of Maria Dobrinas

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Dobrinas. A scholar is included among the top collaborators of Maria Dobrinas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Dobrinas. Maria Dobrinas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Using risk analysis to anticipate and mitigate failures during a hospital pharmacy relocation 2021 ·European Journal of Hospital Pharmacy ·(unknown), Maria Dobrinas, (unknown), (unknown), (unknown), (unknown), (unknown), Nicolas Widmer, (unknown)	3
2	Influence of body weight and UGT2B7 polymorphism on varenicline exposure in a cohort of smokers from the general population 2019 ·European Journal of Clinical Pharmacology ·(unknown), Monia Guidi, Maria Dobrinas, Jacques Cornuz, Chantal Csajka, Chin B. Eap	2
3	Association of nicotine metabolism and sex with relapse following varenicline and nicotine replacement therapy. 2017 ·Experimental and Clinical Psychopharmacology ·(unknown), Maria Dobrinas, Mehdi Gholam‐Rezaee, Rubin Lubomirov, Jacques Cornuz, Chantal Csajka, Chin B. Eap	12
4	Prescription of Sedative Drugs During Hospital Stay: A Swiss Prospective Study 2017 ·Drugs - Real World Outcomes ·(unknown), Maria Dobrinas, (unknown), (unknown), (unknown), Nicolas Widmer	11
5	Transition of care: A set of pharmaceutical interventions improves hospital discharge prescriptions from an internal medicine ward 2016 ·European Journal of Internal Medicine ·(unknown), Maria Dobrinas, (unknown), (unknown), (unknown), (unknown), Nicolas Widmer	14
6	Clinical pharmacist’s role in implementing a smoking cessation intervention in a Swiss regional hospital: an exploratory study 2014 ·International Journal of Clinical Pharmacy ·Maria Dobrinas, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	13
7	Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers 2013 ·Pharmacogenetics and Genomics ·Maria Dobrinas, Jacques Cornuz, Chin B. Eap	18
8	Caffeine intake and CYP1A2 variants associated with high caffeine intake protect non-smokers from hypertension 2012 ·Human Molecular Genetics ·Idris Guessous, Maria Dobrinas, Zoltán Kutalik, Menno Pruijm, Georg Ehret, Marc Maillard, Sven Bergmann, J. Beckmann, Daniele Cusi, Federica Rizzi, Francesco P. Cappuccio, Jacques Cornuz, Fred Paccaud, Vincent Mooser, Jean‐Michel Gaspoz, Gérard Waeber, Michel Burnier, Péter Vollenweider, Chin B. Eap, Murielle Bochud	48
9	Simultaneous determination of antidementia drugs in human plasma: Procedure transfer from HPLC–MS to UPLC–MS/MS 2012 ·Journal of Pharmaceutical and Biomedical Analysis ·Muriel Noetzli, Nicolas Ansermot, Maria Dobrinas, Chin B. Eap	48
10	Contribution of CYP2B6 alleles in explaining extreme (S)-methadone plasma levels 2012 ·Pharmacogenetics and Genomics ·Maria Dobrinas, Séverine Crettol, Beatrice Oneda, (unknown), Margalida Rotger, Eva Choong, Rubin Lubomirov, Chantal Csajka, Chin B. Eap	39
11	Influence of cytochrome P450 oxidoreductase genetic polymorphisms on CYP1A2 activity and inducibility by smoking 2012 ·Pharmacogenetics and Genomics ·Maria Dobrinas, Jacques Cornuz, (unknown), Chin B. Eap	29
12	Chemical contamination during the preparation of cytotoxics: Validation protocol for operators in hospital pharmacies 2012 ·Journal of Oncology Pharmacy Practice ·Farshid Sadeghipour, Kuntheavy Ing Lorenzini, (unknown), Maria Dobrinas, Mapi Fleury, Pascal Bonnabry	13
13	Quantification of nicotine, cotinine, trans-3′-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC–tandem mass-spectrometry procedure for a clinical study on smoking cessation 2011 ·Journal of Chromatography B ·Maria Dobrinas, Eva Choong, Muriel Noetzli, Jacques Cornuz, Nicolas Ansermot, Chin B. Eap	37
14	Impact of Smoking, Smoking Cessation, and Genetic Polymorphisms on CYP1A2 Activity and Inducibility 2011 ·Clinical Pharmacology & Therapeutics ·Maria Dobrinas, Jacques Cornuz, Beatrice Oneda, (unknown), (unknown), Chin B. Eap	90
15	The permeability P-glycoprotein: a focus on enantioselectivity and brain distribution 2010 ·Expert Opinion on Drug Metabolism & Toxicology ·Eva Choong, Maria Dobrinas, Pierre‐Alain Carrupt, Chin B. Eap	22
16	[Genetic aspects of smoking and impact on clinical care]. 2009 ·PubMed ·Maria Dobrinas, Jacques Cornuz, (unknown), (unknown), Chin B. Eap	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact